{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:14:42Z","timestamp":1791846882905,"version":"4.3.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>HIV outbreaks among people who inject drugs (PWID) and experience homelessness are increasing across the USA. Despite high levels of need, multilevel barriers to accessing antiretroviral pre-exposure prophylaxis (PrEP) for HIV prevention persist for this population. The Boston Health Care for the Homeless Program (BHCHP) initiated a low-threshold, outreach-based program to support engagement in PrEP services among PWID experiencing homelessness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To inform dissemination efforts, we explored patient and provider perspectives on key program components. From March to December 2020, we conducted semi-structured qualitative interviews with current and former BHCHP PrEP program participants and prescribers, patient navigators, and outreach workers (i.e., providers). Thematic analysis explored perspectives on key program components.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Participants (\n                      <jats:italic>n<\/jats:italic>\n                      = 21) and providers (\n                      <jats:italic>n<\/jats:italic>\n                      = 11) identified the following five key components of BHCHP\u2019s PrEP program that they perceived to be particularly helpful for supporting patient engagement in PrEP services: (1) community-driven PrEP education; (2) low-threshold,\u00a0accessible programming including same-day PrEP prescribing; (3) tailored prescribing supports (e.g., on-site pharmacy, short-term prescriptions, medication storage); (4) intensive outreach and navigation; and (5) trusting, respectful patient-provider relationships.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Findings suggest that more patient-centered services formed the basis of BHCHP\u2019s innovative, successful PrEP program. While contextual challenges including competing public health emergencies and homeless encampment \u201csweeps\u201d necessitate ongoing programmatic adaptations, lessons from BHCHP\u2019s PrEP program can inform PrEP delivery in a range of community-based settings serving this population, including syringe service programs and shelters.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11606-022-07672-5","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T17:02:28Z","timestamp":1653498148000},"page":"913-921","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Patient and Provider Perspectives on a Novel, Low-Threshold HIV PrEP Program for People Who Inject Drugs Experiencing Homelessness"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6828-1919","authenticated-orcid":false,"given":"Angela R.","family":"Bazzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah C.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie B.","family":"Biello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seamus","family":"Vahey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Brody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"issue":"5 Suppl 1","key":"7672_CR1","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1016\/j.amepre.2021.05.044","volume":"61","author":"D Broz","year":"2021","unstructured":"Broz D, Carnes N, Chapin-Bardales J, et al. Syringe services programs' role in ending the HIV epidemic in the U.S.: why we cannot do it without them. Am J Prev Med 2021;61(5 Suppl 1):S118-S29. https:\/\/doi.org\/10.1016\/j.amepre.2021.05.044 [published Online First: Epub Date]|.","journal-title":"Am J Prev Med"},{"issue":"42","key":"7672_CR2","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.15585\/mmwr.mm7042a1","volume":"70","author":"S Handanagic","year":"2021","unstructured":"Handanagic S, Finlayson T, Burnett JC, Broz D, Wejnert C, National HIVBSSG. HIV infection and HIV-associated behaviors among persons who inject drugs - 23 metropolitan statistical areas, United States, 2018. MMWR Morb Mortal Wkly Rep 2021;70(42):1459-65. https:\/\/doi.org\/10.15585\/mmwr.mm7042a1 [published Online First: Epub Date]|.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"7672_CR3","unstructured":"Centers for Disease Control and Prevention. Estimated HIV incidence in the United States, 2007\u20132010. HIV Surveillance Supplemental Report 2012;17(4). Available at: https:\/\/www.cdc.gov\/hiv\/pdf\/library\/reports\/surveillance\/cdc-hiv-surveillance-supplemental-report-vol-17-4.pdf. Accessed May 2, 2022."},{"issue":"10","key":"7672_CR4","doi-asserted-by":"publisher","first-page":"e569","DOI":"10.1016\/S2352-3018(18)30176-0","volume":"\\","author":"GS Gonsalves","year":"2018","unstructured":"Gonsalves GS, Crawford FW. Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011-15: a modelling study. Lancet HIV 2018;\\(10):e569-e77. https:\/\/doi.org\/10.1016\/S2352-3018(18)30176-0 [published Online First: Epub Date]|.","journal-title":"Lancet HIV"},{"issue":"10","key":"7672_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.15585\/mmwr.mm6810a6","volume":"68","author":"K Cranston","year":"2019","unstructured":"Cranston K, Alpren C, John B, et al. Notes from the field: HIV diagnoses among persons who inject drugs\u2014Northeastern Massachusetts, 2015\u20132018. MMWR Morb Mortal Wkly Rep 2019;68(10):253","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"7672_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2105\/AJPH.2019.305366","volume":"110","author":"C Alpren","year":"2020","unstructured":"Alpren C, Dawson EL, John B, et al. Opioid use fueling HIV transmission in an urban setting: an outbreak of HIV infection among people who inject drugs-Massachusetts, 2015-2018. Am J Public Health 2020;110(1):37-44. https:\/\/doi.org\/10.2105\/AJPH.2019.305366 [published Online First: Epub Date]|.","journal-title":"Am J Public Health"},{"issue":"15","key":"7672_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.15585\/mmwr.mm6815a2","volume":"68","author":"MR Golden","year":"2019","unstructured":"Golden MR, Lechtenberg R, Glick SN, et al. Outbreak of human immunodeficiency virus infection among heterosexual persons who are living homeless and inject drugs\u2014Seattle, Washington, 2018. MMWR Morb Mortal Wkly Rep 2019;68(15):344","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"7672_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2019.1343","volume":"321","author":"AS Fauci","year":"2019","unstructured":"Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA 2019;321(9):844-45. https:\/\/doi.org\/10.1001\/jama.2019.1343[published Online First: Epub Date]|.","journal-title":"JAMA"},{"key":"7672_CR9","unstructured":"Massachusetts Department of Public Health. Data brief: Opioid-related overdose deaths among Massachusetts residents, 2019. Available at: https:\/\/www.google.com\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiNrqnc7sH3AhVSDkQIHZRkD3QQFnoECAIQAQ&url=https%3A%2F%2Fwww.mass.gov%2Fdoc%2Fopioid-related-overdose-deaths-among-ma-residents-november-2020%2Fdownload&usg=AOvVaw06eSDWCwOZN2ggL93hQw7u. Accessed May 2, 2022."},{"issue":"4","key":"7672_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/08897077.2019.1675118","volume":"40","author":"JL Taylor","year":"2019","unstructured":"Taylor JL, Walley AY, Bazzi AR. Stuck in the window with you: HIV exposure prophylaxis in the highest risk people who inject drugs. Subst Abus 2019; 40(4):441-43. https:\/\/doi.org\/10.1080\/08897077.2019.1675118 [published Online First: Epub Date]|.","journal-title":"Subst Abus"},{"issue":"34","key":"7672_CR11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.15585\/mmwr.mm6834a2","volume":"68","author":"RM Gladden","year":"2019","unstructured":"Gladden RM, O\u2019Donnell J, Mattson CL, Seth P. Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine\u201425 states, July\u2013December 2017 to January\u2013June 2018. MMWR Morb Mortal Wkly Rep 2019;68(34):737","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"7672_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.drugpo.2019.10.004","volume":"74","author":"BH Lambdin","year":"2019","unstructured":"Lambdin BH, Bluthenthal RN, Zibbell JE, Wenger L, Simpson K, Kral AH. Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs. Int J Drug Policy 2019;74:299-304. https:\/\/doi.org\/10.1016\/j.drugpo.2019.10.004 [published Online First: Epub Date]|.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"7672_CR13","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10461-008-9432-y","volume":"13","author":"PN Halkitis","year":"2009","unstructured":"Halkitis PN, Mukherjee PP, Palamar JJ. Longitudinal modeling of methamphetamine use and sexual risk behaviors in gay and bisexual men. AIDS Behav 2009;13(4):783","journal-title":"AIDS Behav"},{"key":"7672_CR14","doi-asserted-by":"publisher","first-page":"100398","DOI":"10.1016\/j.abrep.2021.100398","volume":"15","author":"L Brener","year":"2022","unstructured":"Brener L, Caruana T, Broady T, et al. Addressing injecting related risks among people who inject both opioids and stimulants: findings from an Australian survey of people who inject drugs. Addict Behav Rep 2022;15:100398. https:\/\/doi.org\/10.1016\/j.abrep.2021.100398[published Online First: Epub Date]|.","journal-title":"Addict Behav Rep"},{"issue":"6","key":"7672_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/COH.0b013e328358e49e","volume":"7","author":"SD Baral","year":"2012","unstructured":"Baral SD, Stromdahl S, Beyrer C. The potential uses of preexposure prophylaxis for HIV prevention among people who inject drugs. Curr Opin Hiv Aids 2012;7(6):563-8. https:\/\/doi.org\/10.1097\/COH.0b013e328358e49e [published Online First: Epub Date]|.","journal-title":"Curr Opin Hiv Aids"},{"key":"7672_CR16","unstructured":"Centers for Disease Control and Prevention. HIV infection risk, prevention, and testing behaviors among persons who inject drugs\u2014National HIV Behavioral Surveillance: injection drug use, 23 U.S. cities, 2018. HIV Surveillance Special Report 24. http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html. Accessed May 2, 2022, 2020."},{"issue":"3","key":"7672_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.amepre.2020.09.011","volume":"60","author":"JJ Earlywine","year":"2021","unstructured":"Earlywine JJ, Bazzi AR, Biello KB, Klevens RM. High prevalence of indications for pre-exposure prophylaxis among people who inject drugs in Boston, Massachusetts. Am J Prev Med 2021;60(3):369-78. https:\/\/doi.org\/10.1016\/j.amepre.2020.09.011 [published Online First: Epub Date]|.","journal-title":"Am J Prev Med"},{"issue":"5","key":"7672_CR18","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s10461-014-0867-z","volume":"19","author":"DJ Escudero","year":"2015","unstructured":"Escudero DJ, Kerr T, Wood E, et al. Acceptability of HIV Pre-exposure prophylaxis (PREP) among people who inject drugs (PWID) in a Canadian setting. AIDS Behav 2015;19(5):752-7. https:\/\/doi.org\/10.1007\/s10461-014-0867-z [published Online First: Epub Date]|.","journal-title":"AIDS Behav"},{"key":"7672_CR19","doi-asserted-by":"publisher","first-page":"18899","DOI":"10.7448\/IAS.17.1.18899","volume":"17","author":"DJ Escudero","year":"2014","unstructured":"Escudero DJ, Lurie MN, Kerr T, Howe CJ, Marshall BD. HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research. J Int AIDS Soc 2014;17:18899. https:\/\/doi.org\/10.7448\/IAS.17.1.18899[published Online First: Epub Date]|.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"7672_CR20","doi-asserted-by":"publisher","first-page":"e28238","DOI":"10.1371\/journal.pone.0028238","volume":"7","author":"AB Eisingerich","year":"2012","unstructured":"Eisingerich AB, Wheelock A, Gomez GB, Garnett GP, Dybul MR, Piot PK. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. Plos One 2012;7(1):e28238. https:\/\/doi.org\/10.1371\/journal.pone.0028238 [published Online First: Epub Date]|.","journal-title":"Plos One"},{"key":"7672_CR21","doi-asserted-by":"crossref","unstructured":"Kuo I, Olsen H, Patrick R, et al. Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC. Drug Alcohol Depend 2016","DOI":"10.1016\/j.drugalcdep.2016.02.044"},{"key":"7672_CR22","unstructured":"Adams ML, Wejnert C, Finlayson T, Xia M, Paz-Bailey G. HIV Infection, risk, prevention, and testing behaviors among persons who inject drugs: National HIV Behavioral Surveillance: injection drug use, 20 US cities, 2015. 2017"},{"issue":"12","key":"7672_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1089\/apc.2018.0126","volume":"32","author":"AR Bazzi","year":"2018","unstructured":"Bazzi AR, Biancarelli DL, Childs E, et al. Limited knowledge and mixed interest in pre-exposure prophylaxis for HIV prevention among people who inject drugs. AIDS Patient Care STDS 2018;32(12):529-37. https:\/\/doi.org\/10.1089\/apc.2018.0126 [published Online First: Epub Date]|.","journal-title":"AIDS Patient Care STDS"},{"issue":"1","key":"7672_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12954-018-0263-5","volume":"15","author":"KB Biello","year":"2018","unstructured":"Biello KB, Bazzi AR, Mimiaga MJ, et al. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduct J 2018;15(1):55. https:\/\/doi.org\/10.1186\/s12954-018-0263-5 [published Online First: Epub Date]|.","journal-title":"Harm Reduct J"},{"key":"7672_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","volume":"198","author":"DL Biancarelli","year":"2019","unstructured":"Biancarelli DL, Biello KB, Childs E, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend 2019;198:80-86","journal-title":"Drug Alcohol Depend"},{"issue":"9737","key":"7672_CR26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0140-6736(10)60742-8","volume":"376","author":"L Degenhardt","year":"2010","unstructured":"Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet 2010;376(9737):285-301. https:\/\/doi.org\/10.1016\/S0140-6736(10)60742-8 [published Online First: Epub Date]|.","journal-title":"Lancet"},{"issue":"4","key":"7672_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11904-011-0093-5","volume":"8","author":"A Gonzalez","year":"2011","unstructured":"Gonzalez A, Barinas J, O'Cleirigh C. Substance use: impact on adherence and HIV medical treatment. Curr HIV\/AIDS Rep 2011;8(4):223-34. https:\/\/doi.org\/10.1007\/s11904-011-0093-5[published Online First: Epub Date]|.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"4","key":"7672_CR28","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s10461-008-9489-7","volume":"14","author":"M Malta","year":"2010","unstructured":"Malta M, Magnanini MM, Strathdee SA, Bastos FI. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav 2010;14(4):731-47. https:\/\/doi.org\/10.1007\/s10461-008-9489-7 [published Online First: Epub Date]|.","journal-title":"AIDS Behav"},{"issue":"5","key":"7672_CR29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/QAI.0b013e31829f215e","volume":"63","author":"RD Bruce","year":"2013","unstructured":"Bruce RD. Is it time for treatment as prevention among people who inject drugs? J Acquir Immune Defic Syndr 2013;63(5):545-47","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"7672_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s10461-012-0319-6","volume":"17","author":"A Gonzalez","year":"2013","unstructured":"Gonzalez A, Mimiaga MJ, Israel J, Bedoya CA, Safren SA. Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment. AIDS and Behavior 2013;17(1):168-73","journal-title":"AIDS and Behavior"},{"issue":"3","key":"7672_CR31","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.drugalcdep.2010.06.014","volume":"112","author":"MM Azar","year":"2010","unstructured":"Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug and alcohol dependence 2010;112(3):178-93","journal-title":"Drug and alcohol dependence"},{"issue":"1","key":"7672_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/BF02879920","volume":"34","author":"JS Gonzalez","year":"2007","unstructured":"Gonzalez JS, Penedo FJ, Llabre MM, et al. Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence. Ann Behav Med 2007;34(1):46-55. https:\/\/doi.org\/10.1007\/BF02879920 [published Online First: Epub Date]|.","journal-title":"Ann Behav Med"},{"issue":"8","key":"7672_CR33","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1007\/s10461-012-0212-3","volume":"16","author":"SA Springer","year":"2012","unstructured":"Springer SA, Dushaj A, Azar MM. The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV\/AIDS: a systematic review. AIDS Behav 2012;16(8):2119-43. https:\/\/doi.org\/10.1007\/s10461-012-0212-3 [published Online First: Epub Date]|.","journal-title":"AIDS Behav"},{"issue":"4","key":"7672_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11904-011-0093-5","volume":"8","author":"A Gonzalez","year":"2011","unstructured":"Gonzalez A, Barinas J, O\u2019Cleirigh C. Substance use: impact on adherence and HIV medical treatment. Current HIV\/AIDS Reports 2011;8(4):223","journal-title":"Current HIV\/AIDS Reports"},{"issue":"4","key":"7672_CR35","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/COH.0b013e328354bcc8","volume":"7","author":"M-J Milloy","year":"2012","unstructured":"Milloy M-J, Montaner J, Wood E. Barriers to HIV treatment among people who use injection drugs: implications for \u2018treatment as prevention\u2019. Curr Opin Hiv Aids 2012;7(4):332-38","journal-title":"Curr Opin Hiv Aids"},{"issue":"11","key":"7672_CR36","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1097\/QAD.0b013e3282fbd1ed","volume":"22","author":"E Wood","year":"2008","unstructured":"Wood E, Kerr T, Tyndall MW, Montaner JS. A review of barriers and facilitators of HIV treatment among injection drug users. Aids 2008;22(11):1247-56. https:\/\/doi.org\/10.1097\/QAD.0b013e3282fbd1ed [published Online First: Epub Date]|.","journal-title":"Aids"},{"issue":"5","key":"7672_CR37","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/cid\/cit796","volume":"58","author":"MY Karris","year":"2014","unstructured":"Karris MY, Beekmann SE, Mehta SR, Anderson CM, Polgreen PM. Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada. Clin Infect Dis 2014;58(5):704-12. https:\/\/doi.org\/10.1093\/cid\/cit796[published Online First: Epub Date]|.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"7672_CR38","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s10461-016-1612-6","volume":"21","author":"EJ Edelman","year":"2017","unstructured":"Edelman EJ, Moore BA, Calabrese SK, et al. Primary care physicians' willingness to prescribe HIV pre-exposure prophylaxis for people who inject drugs. AIDS Behav 2017;21(4):1025-33. https:\/\/doi.org\/10.1007\/s10461-016-1612-6 [published Online First: Epub Date]|.","journal-title":"AIDS Behav"},{"issue":"4","key":"7672_CR39","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s11904-021-00556-z","volume":"18","author":"KB Biello","year":"2021","unstructured":"Biello KB, Mimiaga MJ, Valente PK, Saxena N, Bazzi AR. The past, present, and future of PrEP implementation among people who use drugs. Curr HIV\/AIDS Rep 2021;18(4):328-38. https:\/\/doi.org\/10.1007\/s11904-021-00556-z [published Online First: Epub Date]|.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"10","key":"7672_CR40","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/hiv.13181","volume":"22","author":"C Grimshaw","year":"2021","unstructured":"Grimshaw C, Boyd L, Smith M, Estcourt CS, Metcalfe R. Evaluation of an inner city HIV pre-exposure prophylaxis service tailored to the needs of people who inject drugs. HIV Med 2021;22(10):965-70. https:\/\/doi.org\/10.1111\/hiv.13181[published Online First: Epub Date]|.","journal-title":"HIV Med"},{"key":"7672_CR41","doi-asserted-by":"publisher","first-page":"108280","DOI":"10.1016\/j.jsat.2021.108280","volume":"124","author":"JL Taylor","year":"2021","unstructured":"Taylor JL, Ruiz-Mercado G, Sperring H, Bazzi AR. A collision of crises: addressing an HIV outbreak among people who inject drugs in the midst of COVID-19. J Subst Abuse Treat 2021;124:108280. https:\/\/doi.org\/10.1016\/j.jsat.2021.108280 [published Online First: Epub Date]|.","journal-title":"J Subst Abuse Treat"},{"key":"7672_CR42","unstructured":"Massachusetts Department of Public Health & the Boston Public Health Commission. Increase in newly diagnosed HIV infections among persons who inject drugs in Boston, 2019. Available at: https:\/\/www.bphc.org\/whatwedo\/infectious-diseases\/Documents\/Joint_HIV_in_PWID_advisory_012519%20(1).pdf. Accessed May 2, 2022."},{"key":"7672_CR43","doi-asserted-by":"publisher","unstructured":"Biello KB, Bazzi AR, Vahey S, Harris M, Shaw L, Brody J. Delivering preexposure prophylaxis to people who use drugs and experience homelessness, Boston, MA, 2018-2020. Am J Public Health 2021;111(6):1045-48. https:\/\/doi.org\/10.2105\/AJPH.2021.306208 [published Online First: Epub Date]|.","DOI":"10.2105\/AJPH.2021.306208"},{"issue":"4","key":"7672_CR44","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1007\/s10461-017-2009-x","volume":"22","author":"JC Hojilla","year":"2018","unstructured":"Hojilla JC, Vlahov D, Crouch PC, Dawson-Rose C, Freeborn K, Carrico A. HIV pre-exposure prophylaxis (PrEP) uptake and retention among men who have sex with men in a community-based sexual health clinic. AIDS Behav 2018;22(4):1096-99. https:\/\/doi.org\/10.1007\/s10461-017-2009-x [published Online First: Epub Date]|.","journal-title":"AIDS Behav"},{"key":"7672_CR45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.drugpo.2017.12.009","volume":"53","author":"C Leon","year":"2018","unstructured":"Leon C, Cardoso LJP, Johnston S, Mackin S, Bock B, Gaeta JM. Changes in public order after the opening of an overdose monitoring facility for people who inject drugs. Int J Drug Policy 2018;53:90-95. https:\/\/doi.org\/10.1016\/j.drugpo.2017.12.009 [published Online First: Epub Date]|.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"7672_CR46","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1080\/08897077.2021.1876201","volume":"42","author":"G Wishik","year":"2021","unstructured":"Wishik G, Gaeta JM, Racine MW, O'Connell JJ, Baggett TP. Substance consumption and intoxication patterns in a medically supervised overdose prevention program for people experiencing homelessness. Subst Abus 2021;42(4):851-57. https:\/\/doi.org\/10.1080\/08897077.2021.1876201[published Online First: Epub Date]|.","journal-title":"Subst Abus"},{"key":"7672_CR47","unstructured":"Boston Public Health Commission. Engagement Center. Secondary Engagement Center 2021. Available at: https:\/\/www.bphc.org\/whatwedo\/Recovery-Services\/roadmap-to-recovery\/Programs-and-Services\/Pages\/Engagement-Center.aspx. Accessed May 2, 2022."},{"key":"7672_CR48","volume-title":"Techniques and Procedures for Developing Grounded Theory","author":"JM Corbin","year":"2008","unstructured":"Corbin JM, Strauss AL. Basics of Qualitative Research (3rd ed.): Techniques and Procedures for Developing Grounded Theory. Thousand Oaks, California, 2008.","edition":"3"},{"key":"7672_CR49","volume-title":"Selecting Ethnographic Informants","author":"JC Johnson","year":"1990","unstructured":"Johnson JC. Selecting Ethnographic Informants. Newbury Park, CA: Sage Publications, 1990."},{"issue":"1","key":"7672_CR50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822\u00d705279903","volume":"18","author":"G Guest","year":"2016","unstructured":"Guest G, Bunce A, Johnson L. How many interviews are enough? Field Methods 2016;18(1):59-82. https:\/\/doi.org\/10.1177\/1525822\u00d705279903[published Online First: Epub Date]|.","journal-title":"Field Methods"},{"issue":"2","key":"7672_CR51","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/1525822\u00d710388468","volume":"23","author":"JT DeCuir-Gunby","year":"2010","unstructured":"DeCuir-Gunby JT, Marshall PL, McCulloch AW. Developing and using a codebook for the analysis of interview data: an example from a professional development research project. Field Methods 2010;23(2):136-55. https:\/\/doi.org\/10.1177\/1525822\u00d710388468[published Online First: Epub Date]|.","journal-title":"Field Methods"},{"issue":"2","key":"7672_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/1525822\u00d7980100020301","volume":"10","author":"KM MacQueen","year":"2016","unstructured":"MacQueen KM, McLellan E, Kay K, Milstein B. Codebook development for team-based qualitative analysis. CAM Journal 2016;10(2):31-36. https:\/\/doi.org\/10.1177\/1525822\u00d7980100020301 [published Online First: Epub Date]|.","journal-title":"CAM Journal"},{"key":"7672_CR53","doi-asserted-by":"publisher","first-page":"103284","DOI":"10.1016\/j.drugpo.2021.103284","volume":"96","author":"JK Brody","year":"2021","unstructured":"Brody JK, Taylor J, Biello K, Bazzi AR. Towards equity for people who inject drugs in HIV prevention drug trials. Int J Drug Policy 2021;96:103284. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103284 [published Online First: Epub Date]|.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"7672_CR54","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1097\/QAI.0000000000002558","volume":"86","author":"AM Roth","year":"2021","unstructured":"Roth AM, Tran NK, Felsher M, et al. Integrating HIV preexposure prophylaxis with community-based syringe services for women who inject drugs: results from the project SHE demonstration study. Journal of acquired immune deficiency syndromes 2021;86(3):e61-e70. https:\/\/doi.org\/10.1097\/QAI.0000000000002558[published Online First: Epub Date]|.","journal-title":"Journal of acquired immune deficiency syndromes"},{"issue":"6","key":"7672_CR55","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s11904-021-00578-7","volume":"18","author":"E Rousseau","year":"2021","unstructured":"Rousseau E, Julies RF, Madubela N, Kassim S. Novel platforms for biomedical HIV prevention delivery to key populations - community mobile clinics, peer-supported, pharmacy-led PrEP delivery, and the use of telemedicine. Curr HIV\/AIDS Rep 2021;18(6):500-07. https:\/\/doi.org\/10.1007\/s11904-021-00578-7[published Online First: Epub Date]|.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"12","key":"7672_CR56","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1007\/s10461-020-02911-4","volume":"24","author":"T Walsh","year":"2020","unstructured":"Walsh T, Schneider JA, Ardestani BM, Young LE. Individual and social network structure characteristics associated with peer change agent engagement and impact in a PrEP intervention. AIDS Behav 2020;24(12):3385-94. https:\/\/doi.org\/10.1007\/s10461-020-02911-4[published Online First: Epub Date]|.","journal-title":"AIDS Behav"},{"issue":"6","key":"7672_CR57","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1007\/s10461-020-03115-6","volume":"25","author":"M Felsher","year":"2021","unstructured":"Felsher M, Koku E, Bellamy SL, Mulawa MI, Roth AM. Predictors of willingness to diffuse PrEP information within ego-centric networks of women who inject drugs. AIDS Behav 2021;25(6):1856-63. https:\/\/doi.org\/10.1007\/s10461-020-03115-6[published Online First: Epub Date]|.","journal-title":"AIDS Behav"},{"issue":"6","key":"7672_CR58","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s10461-020-03111-w","volume":"25","author":"ND Crawford","year":"2021","unstructured":"Crawford ND, Myers S, Young H, Klepser D, Tung E. The role of pharmacies in the HIV prevention and care continuums: a systematic review. AIDS Behav 2021;25(6):1819-28. https:\/\/doi.org\/10.1007\/s10461-020-03111-w[published Online First: Epub Date]|.","journal-title":"AIDS Behav"},{"issue":"1 (91)","key":"7672_CR59","first-page":"195","volume":"30","author":"R Amster","year":"2003","unstructured":"Amster R. Patterns of exclusion: sanitizing space, criminalizing homelessness. Social Justice 2003;30(1 (91)):195-221","journal-title":"Social Justice"},{"issue":"1","key":"7672_CR60","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1177\/1078087417690833","volume":"55","author":"T Robinson","year":"2017","unstructured":"Robinson T. No right to rest: police enforcement patterns and quality of life consequences of the criminalization of homelessness. Urban Affairs Review 2017;55(1):41-73. https:\/\/doi.org\/10.1177\/1078087417690833 [published Online First: Epub Date]|.","journal-title":"Urban Affairs Review"},{"key":"7672_CR61","first-page":"2020","volume":"10","author":"AM Barry-Jester","year":"2020","unstructured":"Barry-Jester AM. Sweeps of homeless camps in California aggravate key health issues. NPR 2020 January 10, 2020.","journal-title":"NPR"},{"issue":"4","key":"7672_CR62","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/10511482.2018.1424723","volume":"28","author":"J Darrah-Okike","year":"2018","unstructured":"Darrah-Okike J, Soakai S, Nakaoka S, Dunson-Strane T, Umemoto K. \u201cIt Was Like I Lost Everything\u201d: the harmful impacts of homeless-targeted policies. Housing Policy Debate 2018;28(4):635-51. https:\/\/doi.org\/10.1080\/10511482.2018.1424723[published Online First: Epub Date]|.","journal-title":"Housing Policy Debate"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-022-07672-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-022-07672-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-022-07672-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T15:31:52Z","timestamp":1679671912000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-022-07672-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["7672"],"URL":"https:\/\/doi.org\/10.1007\/s11606-022-07672-5","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"17 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Drs. Biello and Bazzi report grants from NIH\/NIDA during the conduct of this study. Dr. Biello reports receiving unrestricted research funds from Merck outside of the submitted work. The other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}